Company Overview and News

to your dashboard

Headline News

Cellmid ends the year on a high note after achieving quarterly targets

Cellmid Limited (ASX:CDY) has achieved key milestones and operational targets for the quarter ended 31 December 2017.

Cellmid receives funding from US strategic investor

Cellmid Limited (ASX:CDY) has received $1 million in the form of a strategic investment from US based investor, Dennis Eck.

Cellmid makes move to sell hair loss products into China

Cellmid Limited (ASX:CDY) has signed a master supply agreement with YPB Group Ltd (ASX:YPB) to market the company’s évolis hair loss products in China.

Cellmid's directors show vote of confidence with on-market buying spree

Cellmid Ltd (ASX:CDY) has been busy this week showcasing the recently published FGF5 inhibitor clinical data at the World Congress for Hair Research in Kyoto, Japan. (0-1)

Cellmid's newly appointed director Dr Martin Cross lifts indirect stake on-market

Cellmid Ltd (ASX:CDY) just last month appointed the experienced Dr Martin Cross as a non-executive director, a highly regarded pharmaceutical executive with over 30 years’ experience.

Cellmid steps onto world stage for hair research in Japan

Cellmid (ASX:CDY) will be presenting the recently published FGF5 inhibitor clinical data at the World Congress for Hair Research in Kyoto, Japan.

Cellmid lifts revenue options after taking clinically validated hair products to Tokyo

Cellmid Ltd (ASX:CDY) continues its global roll-out and has now opened its first Advangen Hair Biology concept store in Tokyo, Japan.

Cellmid to benefit from share consolidation as revenues grow

Cellmid Ltd (ASX:CDY) is proposing a consolidation of its securities at the ratio of 20 to 1 during the upcoming Annual General Meeting.

Cellmid's Maria Halasz discussed growing revenue streams at Proactive's CEO Sessions

Cellmid's (ASX:CDY) chief executive, Maria Halasz, joined Proactive's CEO Sessions in Sydney on Tuesday 3rd October and Melbourne on Tuesday 4th October.

Cellmid gets tax incentive for melanoma, hair growth research programs

Cellmid Limited (ASX:CDY) has received $947,000 from the Australian Taxation Office under the Research and Development Tax Incentive Scheme for the 2017 financial year.

Cellmid's Maria Halasz brings growing revenues to Proactive's CEO Sessions

Cellmid Ltd (ASX:CDY) continues to grow revenues from its consumer health division, through the wholly-owned subsidiary Advangen, which sells hair growth products. (1-0)

Gold Road to showcase Gruyere Joint Venture at the Proactive's CEO Sessions

Gold Road Resources Ltd (ASX:GOR) is pioneering development of Australia’s newest goldfield, the Yamarna Belt, 200 kilometres east of Laverton in Western Australia. (1-0)

Cobalt Blue's Joe Kaderavek to discuss next Thackaringa steps at Proactive's CEO Session in Sydney

Cobalt Blue Holdings (ASX:COB) is preparing for the next stage of field work, which is about to commence at its Thackaringa Cobalt Project near Broken Hill in New South Wales. (1-0)

Altech's Iggy Tan brings high purity alumina plans to Proactive's CEO Sessions

Altech Chemicals Ltd (ASX:ATC,FRA:A3Y) is aiming to become one of the world's leading suppliers of 99.99% (4N) high purity alumina (HPA). (1-0)

Silver City's Chris Torrey brings Copper Blow drilling program to Proactive's CEO Sessions

Silver City Minerals Ltd (ASX:SCI) is currently exploring in one of the best post codes in the world, being just 20 kilometres from Broken Hill in New South Wales. (1-0)